Literature DB >> 15231423

An ongoing randomized clinical trial in dysphagia.

JoAnne Robbins1, Jackie Hind, Jerilyn Logemann.   

Abstract

UNLABELLED: Most of us who have clinical practices firmly contend that the treatments we provide cause beneficial changes in the lives of our patients. Indeed, our clinical experience engenders strong convictions to the point of believing that withholding treatment creates ethical violations. Intellectually, however, we must recognize that the value of treatment needs to be validated through scientific evidence. This paper examines the use of randomized clinical trials as a means of obtaining the type of evidence relevant for work in health care settings. LEARNING OUTCOMES: (1) Readers will be able to explain why randomized clinical trials are conducted. (2) Readers will be able to describe the challenges faced when conducting randomized clinical trials. (3) Readers will be able to explain the ethical considerations involved in study design. (4) Readers will be able to describe the implementation and procedures used in Protocol 201. (5) Readers will be able to describe the two dysphagia interventions and the expected short and long-term effects of these interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231423     DOI: 10.1016/j.jcomdis.2004.04.006

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  1 in total

Review 1.  Update on clinical trials in Dysphagia.

Authors:  Jeri A Logemann
Journal:  Dysphagia       Date:  2006-04       Impact factor: 3.438

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.